SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-021960
Filing Date
2020-05-06
Accepted
2020-05-06 16:22:04
Documents
52
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q atra-10q_20200331.htm   iXBRL 10-Q 2080131
2 EX-31.1 atra-ex311_9.htm EX-31.1 16107
3 EX-31.2 atra-ex312_7.htm EX-31.2 16140
4 EX-32.1 atra-ex321_10.htm EX-32.1 8031
  Complete submission text file 0001564590-20-021960.txt   6335112

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA atra-20200331.xsd EX-101.SCH 39977
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atra-20200331_cal.xml EX-101.CAL 40577
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atra-20200331_def.xml EX-101.DEF 114054
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE atra-20200331_lab.xml EX-101.LAB 319741
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atra-20200331_pre.xml EX-101.PRE 228762
20 EXTRACTED XBRL INSTANCE DOCUMENT atra-10q_20200331_htm.xml XML 1126161
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36548 | Film No.: 20852926
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences